Progressive Care Inc. Garners News Coverage in Leading Financial Publications, Yahoo Finance and Benzinga on Its Efforts to End the Opioid Crisis
MIAMI, Dec. 18, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered news coverage in leading financial publications Yahoo Finance and Benzinga on its ongoing work towards ending the opioid epidemic.
“We are honored to have Progressive Care’s efforts toward improving the opioid crisis in such noteworthy publications,” said S. Parikh Mars, CEO of Progressive Care Inc. “We are passionate about providing the public with opioid alternatives to ensure a safer future for our patients.”
In a contributed article titled “If The Cannabis Industry Is Serious About Health Care, It Must Learn From The Opioid Crisis”, published December 14, 2018, in Benzinga, Mars focuses on the future of healthcare and the importance of making it personal and not driven by the same bottom-line logic that helped fuel the opioid crisis.
In the piece, Mars writes: “Technology should make healthcare more personal, not less,” she said. “We want it to be patient-centered care, not patient-burden care.”
Progressive Care has remained committed to taking steps to create a personal healthcare system for the public, most recently with the launch of their new proprietary tele-pharmacy software Tele-PharmCo.
The technology will facilitate two-way video conferencing between patients, healthcare professionals, and PharmCo’s team of pharmacists and pharmacy technicians through a secure video interface, allowing patients and their care providers to connect and interact with licensed pharmacists and pharmacy technicians in real-time and speak directly about any medical concerns.
The recent media coverage comes after the company’s efforts to provide its network with more healthcare informational resources through PharmCo Pharmacy. Additional commentary from Progressive Care’s CEO about the company and industry as a whole can be found on the Progressive Care blog and PharmCo blog.
For more immediate updates on the company’s media coverage, connect with Progressive Care and PharmCo on social media:
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Kathleen Gonzales, CMW Media
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development